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A COMPETITION BINDING ASSAY FOR DETERMINATION OF THE 
INOSITOL (1,4,5)-TRISPHOSPHATE CONTENT OF HUMAN LEUCOCYTES 
Peter H. Nibbering’, Timo P.L. Zomerdijk’, Peter J.M. van Haastert’, 
and Ralph van Furth’,* 
‘Dept. of Infectious Diseases , University Hospital, Leiden, The Netherlands 
’ Dept. of Biochemistry , University of Groningen, The Netherlands 
Received June 13, 1990 
SUMMARY: We developed a competition binding assay for estimation of the 
intracellular inositol (1,4,5)-trisphosphate (Ins( 1,4,5)P,) and optimalized it for the 
measurement of the Ins(1,4,5)P, content of human blood leucocytes. The present method 
is considerably cheaper and requires five times fewer cells than the commercial 
Ins(1,4,5)P, kit. The mean Ins(1,4,5)P, content of human blood monocytes, granulocytes, 
and lymphocytes amounted to 3.3k1.2 PM, 3.1f1.4 pM, and 4.6k1.5 PM, respectively. 
After stimulation with formyl-methionyl-leucyl-phenylalanine (f-MLP) the Ins(1,4,5)P, 
content of human granulocytes and monocytes increased 2-3 times within 10 set and then 
gradually decreased, returning to basal values at 60 sec. Lymphocytes did not respond to 
f-MLP with an increase in their Ins(l,4,5)P, content. 0 1990 Academx PT~SS. W. 
Quantification of the cellular lns(1,4,5)P, content is usually performed in cells 
loaded with 32[P]-labeled phosphate or myo-(2-‘[HI)-inositol (2.?[H]-Ins) until an 
equilibrium between radiolabeled phosphatidylinositol (4,5)-bisphosphate (PtdIns(4,5)P,) 
and radiolabeled Ins has been reached (l-3). It is assumed that all pools of 
inositolphosphates have then been labeled to equilibrium. After loading, the 
inositolphosphates are extracted from the cells and analysed by chromatography (4-7). 
These procedures have certain drawbacks: 2-3[H]-Ins is poorly taken up by cells and 
chromatographic analysis is complex and time-consuming. Several methods have been 
developed to assess the Ins(1,4,5)P, content of cells without the introduction of labeled 
phosphate or Ins (S-11). Only the competition binding assay (9) does not rely on 
chromatographic analysis of the extracted inositolphosphates. This assay takes advantage 
*To whom correspondence should be addressed. 
Abbreviations used: InsP,,, myo-inositol mono-, bis-, tris-, tetrakis-, pentakis-, hexakis- 
phosphate, with positional isomerism of phosphoesters as indicated in parentheses; 
GroInsP,, glycerophosphoinositol monophosphate; Ins, myo-inositol; PBS, phosphate- 
buffered saline; cpm, counts per minute; PtdIns(4,5)P,, phosphatidylinositol 
(4,5)bisphosphate; BSA, bovine serum albumin; B and B,, cpm Ins(l,4,5)P, in the 
presence and absence of unlabeled compound, respectively. 
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of saturable, high affinity binding sites for lns(1,4,5)P, in microsomal fractions from 
bovine adrenal cortex (12). A modification of the competition radiobinding assay is 
commercially available and has recently been applied to quantify the Ins( 1,4,5)P, content 
of slime mold cells (13). Unfortunately, this commercial kit is expensive and requires 
large numbers of cells. The purpose of the present study was to develop an alternative 
competition radiobinding assay that would be optimal for the measurement of the 
lns( 1,4,5)P, content of human leucocytes and changes in it upon stimulation. 
MATERIALS AND METHODS 
Preparation of cell lvsates. Blood collected from healthy donors by venepuncture was 
subjected to Ficoll-Hypaque centrifugation (p=1.077; Pharmacia Inc., Uppsala, Sweden) at 
440 x g for 20 min at 18°C. After resuspension- of the pellet in phosphate-buffered saline 
(PBS, pH 7.4) the granulocytes were purified by plasmasteril (Fresenius A.G., Bad 
Homburg, FRG) sedimentation (1 x g) for 10 min at 37°C washed in PBS and the 
contaminating erythrocytes were lysed with distilled water. The monocyte- and 
lymphocyte-enriched preparations were isolated from the Ficoll-Hypaque interphase by 
elutriation centrifugation with a Beckman 52-21 centrifuge (Beckmann Instruments, 
Mijdrecht, The Netherlands) as described (14) and resuspended in PBS. In all cell 
suspensions; viability exceeded 95% as determined by trypan-blue exclusion. 
To extract the inositolphosphates from the cells, 100 ~1 icecold 3.5% voI/vol 
perchloric acid was added to loo-p1 aliquots of lo8 cells/ml, and after 20 min at 4°C 
these samples were centrifuged for 1 min at 7,000 x g. Next, the supernatants were 
neutralized with 50 pl saturated sodium bicarbonate for 20 min at 4°C centrifuged for 1 
min at 7,000 x g and the acquired supernatants were stored at -20°C for up to 2 months. 
Neutralized perchloric acid-treated PBS served as a control. 
Stimulation of leucocvtes with f-MLP. Leucocytes were exposed to 1 pM formyl- 
methionyl-leucyl-phenylalanine (f-MLP; Sigma Chemical CO., St. Louis, MO, USA) 
dissolved in dimethylsulfoxide (DMSO, Serva, Heidelberg, FRG) and diluted in PBS. 
Stimulation was stopped at selected times (O-300 sets) by the addition of icecold 3.5% 
perchloric acid. As control, cells were exposed to PBS with an equivalent concentration 
of DMSO for the same intervals. 
Comnetition radiobindina assay for lns(1,4.5)P, Microsomal preparations originating from 
bovine adrenal cortex were obtained as described (12). Briefly, bovine adrenal cortices, 
dissected free of fat and medullary tissue, were homogenized with a blender (Braun, 
Frankfurt, FRG) in 20 mM sodium hydrogencarbonate and centrifuged for 10 min at 500 
x g to remove large pieces of tissue. The supematant was centrifuged for 20 min at 
25,000 x g, and then the pellet was washed and diluted in 20 mM Tris-HCl-buffer 
(pH 7.5) to a total protein content of about 15 mg/ml. Protein was determined according 
to Markwell et al. (15), with serial dilutions of bovine serum albumin (BSA) used as 
standards. 2-3[H]-lns( 1,4,5)P, (specific activity 20-60 Ci/mmol) and unlabeled Ins( 1,4,5)P, 
were purchased from Amersham International, Amersham, Bucks, UK). 
Next, 20 pl cell lysate, 20 1.11 0.1 M Tris-HCl-buffer (pH 9) supplemented with 
4 mM EDTA and 0.4% BSA, 20 pl of the optimal dilution of 2-3H-lns(1,4,5)P,, and 20 
pl microsomal preparation were pipetted into an Eppendorf vial. Binding of Ins(1,4,5)P3, 
to components of the microsomal preparation was allowed to continue for 20 min at 0°C. 
Bound 2-3[H]-lns(1,4,5)P, was then separated from free 2-3[H]-Ins( 1,4,5)P3, by 
centrifugation of the mixture for 2 min at 10,000 x g, the supematant was then discarded, 
and the pellet resuspended in 100 yl PBS and mixed with 1.0 ml insta-gel (Packard 
Chemical Operations, Groningen, The Netherlands) for liquid scintillation counting for 10 
min. The amount of lns(1,4,5)P, in the cell lysate was quantified by comparison with the 
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standard curve based on serial dilutions of unlabeled Ins(1,4,5)P, (Amersham) made in 
saline (range 0 to 2.5 pmol Ins(1,4,5)PJ20 ~1). The mean intracellular Ins( 1,4,.5)P, 
concentrations were calculated from the amount of Ins( 1,4,5)P, and the mean cell volume 
of the leucocytes (16). 
Specific binding values were used to compare the various batches of bovine 
adrenal cortex microsomal preparation with respect to binding of 2-“[HI-Ins(1,4,5)P,. To 
calculate the specific binding, we determined the non-specific binding, i.e., binding of 2- 
3[H]-Ins(1,4,5)P, to the microsomal preparation in the excess of unlabeled lns(1,4,5)P,, 
and total binding, i.e, binding of 2-‘[HJ-lns(l,4,5)P, in the absenw of unlabeled 
Ins( 1,4,5)P,. 
Fractionation of inositolphosphates in granulocyte lvsates. Inositolphosphates in lysates of 
granulocytes were separated on a Dowex AG l-X8 (formate-form; mesh size: 200-400; 
BioRad Laboratories, Richmond, CA, USA) as described (Berridge, 1983). The standards 
were 2-3[H]-Ins, 2-3[H]-Ins(l)P,, 2-3[H]-Ins(1,4)P,, and 2-3[H]-Ins(1,4,5)P, (all from 
Amersham). 
RESULTS 
Optimalization of the competition binding assay. To determine the optimal conditions for 
the interaction between Ins(1,4,5)P, and its binding sites in the microsomal preparation, a 
known amount of 2-3[H]-lns(l,4,5)P, was mixed with a fixed amount of microsomal 
preparation under varying conditions. Binding of - 7-3[H]-Ins( 1,4,5)P, to components of the 
microsomal preparation was maximal after 20 min at 0°C independent of the pH of the 
Ins(l,4,5)P,-containing buffer (pH range 7 to 1 l), but decreased with increasing 
concentrations of sodium chloride in the buffer (results not shown). In all further 
experiments Ins(1,4,5)P, was therefore dissolved in saline. Specific binding of 
2-3[H]-Ins(1,4,5)P, was maximal when 20-pl microsomal preparation and about 1200 cpm 
2-3[H]-Ins( 1,4,5)P, were used. Under these conditions, median specific and non-specific 
binding amounted to 30% (range 29%-33%) and 7% (6%-lo%), respectively, (four 
different batches of microsomal preparation; for each batch: n=12 experiments). 
In connection with the possibility that perchloric acid treatment of cells degraded 
PtdIns(4,5)P, to form Ins(1,4,5)P,, we exposed various amounts of PtdIns(4,S)P,, ranging 
from 10 pmol to 1 nmol dissolved in 100 pl PBS, to 100 ~1 3.5% perchloric acid and 
then neutralized the mixture with 50 pl saturated sodiumbicarbonate. Equal amounts of 
PtdIns(4,5)P, dissolved in 250 ~1 PBS served as control. Next, the amount of material 
competing with 2-3[H]-Ins( 1,4,5)P, for binding to components of the microsomal 
preparation was determined. No differences were found between the values for perchloric 
acid-treated and control samples PtdIns(4,5)P, (n=3; p<O.Ol). Furthermore, the efficiency 
of extraction of 2-3[H]-Ins(1,4,5)P, was higher than 90% (results not shown). 
Measurements of the Ins(1,4,5)P, content were highly reproducible, since the intra- 
assay coefficient of variation ranged from 7 to 18% (four batches of cell lysate; each 
determined at least in quadruplicate) and the inter-assay coefficient of variation from 12- 
16% (three batches of cell lysate). 
757 
Vol. 170, No. 2, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
Snecificitv of the competition binding assay. 
To find out whether other compounds besides Ins(l,4,5)P, interact with binding 
sites in the microsomal preparation, we fractionated a human granulocyte extract on a 
Dowex AG l-X&column and the presence of material competing with 2-J[Hj-Ins( 1,4,S)P, 
for binding to sites in the microsomal preparation determined. Only the Ins( 1,4,5)P,- 
containing fraction was able to compete with 2-31HJ-Ins(1,4,5)P, for binding to such sites 
(Fig. 1). Further, we investigated the specificity of the competition radiobinding assay by 
incubating a granulocyte extract together with an optimal dilution of an Ins(1,4,5)P,-S- 
phosphatase preparation (a generous gift of Dr. C. Erneux, Free University of Brussels, 
Belgium) for 60 min at room temperature and determined the amount of the cross- 
reacting activity in the extract with the competition binding assay. This enzyme reduced 
the cross-reacting activity in the granulocyte extract by 70%, which is comparable to the 
enzymatical degradation of “P-Ins( 1,4,5)P, (New England Nuclear Research Products, 
DuPont de Nemours BV, ‘s-Hertogenbosch, The Netherlands) added to the granulocyte 
extract, which amounts to 71%. 
Addition of high concentrations (up to 1 PM) of c-AMP or c-GMP (Amersham), 
did not affect the binding of 2-3[H]-Ins( 1,4,S)P, to sites in the microsomal preparation 
(results not shown). However, 0.5 nmol or more PtdIns(4,5)P, competed with labeled 
Ins(1,4,5)P, for binding to sites in the microsomal preparation; on a molar basis binding 
of PtdIns(4,5)P, to such components was about 1000 times lower than that of Ins(1,4,5)P, 
(Fig. 2). Since the PtdIns(4,5)P, content of human leucocytes lies roughly between 1 and 
300 1 Im Gro-IlISP, InsP, lnsPp IWP 3 IlISP 4-E 
0 IO 20 30 40 50 60 
fraction number 
Fig. 1. Competition between the various fractions containing inositolphosphates and 2- 
‘[HI-Ins(l,4,5)P, for binding to sites in the adrenal cortex microsomal preparation. 
Extracts of human granulocytes were made with icecold 3.5% perchlorlc acid 
followed by neutralization with saturated sodium hydrogencarbonate. Inosltolphosphates 
were fractionated on an AC l-X8 column using Ins, Ins( l)P,, Ins(l,4)P,, and Ins( 1,4,S)P, 
as standards. All fractions were screened for cross-reactivity in the competition binding 
assay. Only the fractions containing Ins( 1,4,5)P, displayed cross-reactivity. 
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FiE,. 2: Binding of Ins(1,4,5)P, or PtdIns(4,5)P, to Ins(l,4,5)P,-binding sites in bovine 
adrenal cortex microsomal preparation. 
Competition between Ins(1,4,5)P, (closed symbols) or PtdIns(4,5)P, (open 
symbols) and 2-3[H]-Ins(1,4,5)P, for binding to sites in a bovine adrenal cortex 
microsomal preparation was determined with the competition binding assay. Cpm bound 
2-3[H]-Ins(1,4,5)P, in the presence of the various amounts of the unlabeled compound (B) 
and cpm bound 2-3[HJ-Ins(1,4,5)P, in the absence of the unlabeled compound (B,,) were 
determined. B is expressed as a percentage of B,. The results are means and standard 
deviations of three experiments: each value is based on at least quadruplicate 
determinations. 
Fig. 3. Effect of f-MLP on the Ins(1,4,5)P, content of human granulocytes. 
Granulocytes were stimulated with 1 PM f-MLP (closed symbols) or with 10d 
M DMSO (control; open symbols) for selected intervals and extracts of these 
leucocytes were made. The Ins (1,4,S) P, content of the these cell exttmcts was 
determined with the competition binding assay. Between 5 and 30 set after 
f-MLP stimulation, the values for Ins( 1,4,S)P, of granulocytes but not lymphocytes 
increased (~~0.01) relative to basal values and control values. The values are expressed 
as the mean and standard deviation for four experiments (measured in quadruphcatr). 
5 nmol per 1x10’ cells (based on values for the brains, 17,18), the possibility that the 
Ins( 1,4,5)P,-containing fraction of the cell lysates is contaminated with substantial 
amounts of PtdIns(4,5)P, was investigated. For this purpose we determined the organic 
phosphate content of this fraction of a lysate of 2x10* granulocytes as described (19). In 
this concentrated cell lysate the amount of organic phosphate lay below the detection 
level of 5 pmol (results not shown). 
Changes in the intracellular Ins(1,4.S)P, content of blood leucocytes after stimulation with 
f-MLP. The mean and sd intracellular Ins(1,4,5)P, content of human blood monocytes, 
granulocytes, and lymphocytes amounted to 3.3f1.2 uM, 3.1k1.4 PM, and 4.hfl.S PM, 
respectively. Neutralized perchloric acid-treated PBS did not affect the binding of 
2-3[H]-Ins( 1,4,5)P, to the binding sites in the microsomal preparation (results not shown). 
After stimulation with f-MLP the Ins( 1,4,5)P, content of human granulocytes (Fig. 3 ) 
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and monocytes (results not shown) increased about 2-3 times within 10 set and then 
gradually decreased, returning to basal values at 60 sec. Lymphocytes did not respond to 
f-MLP with a rise of their Ins(1,4,5)P, content. 
DISCUSSION 
The present competition binding assay for Ins(1,4,5)P, is rapid, convenient, and 
does not require loading of the cells with labeled probes or chromatographic separation of 
inositolphosphates. Since perchloric acid treatment of the cells does not lead to 
Ins(1,4,5)P, formation from PtdIns(4,5)P, and the recovery of Ins(1,4,S)P, after extraction 
was excellent, it may be concluded that the Ins( 1,4,5)P, content of the cell lysate 
represented that of intact cells. Measurements of the Ins( 1,4,S)P, content of cells 
performed on the same day as well as on different days were reproducible. The results 
obtained with different batches of adrenal cortex microsomal preparation can be 
compared with each other without any correction. 
Several lines of evidence point to the specificity of the method. It has been 
reported that of all inositolphosphates studied only Ins(1,4,5)P, and to a considerably 
smaller degree some isomers of lns(1,4,S)P, and Ins(1,3,4,5)P, can compete with 2-j[H]- 
lns(1,4,5)P, for binding to its receptor (20). We found that only Ins( 1,4,5)P,-containing 
fractions of a human granulocyte extract, obtained by chromatography on a AG l-X8- 
column, were able to compete with 2-‘[HI-Ins(1,4,5)P, for binding to sites in the 
microsomal preparation. However, other inositoltrisphosphate isomers besides Ins(l,4,5)P, 
coeluted with this method. The possibility that Ins(1,3,4)P,, the major contaminant in the 
Ins(1,4,5)P, fraction, binds to components of the adrenal cortex microsomal preparation 
has been excluded, since Ins( 1,4,5)P,-5phosphatase reduced the cross-reactivity of the 
granulocyte extract to the same extent as it did degrade 32[P]-Ins(1,4,5)P,. It cannot be 
entirely excluded that Ins(l,2-cyclic,4,5)P, is not determined with the assay. However, in 
the present study this cyclic isomer of Ins(1,4,S)P, probably did not play a role, since 
resting cells contain only small amounts of this isomer and little is formed after brief 
stimulation (21). We also found that other second messengers, such as c-AMP and c- 
GMP, did not inhibit the binding of 2-3[H]-lns(1,4,5)P, to the adrenocortical preparation. 
PtdIns(4,5)P, inhibited the binding of 2-3[H]-lns( 1,4,5)P, to the microsomal preparation. 
This cross-reactivity did not affect the present results, since the neutralized perchloric 
acid cell extracts do not contain detectable amounts of phospholipid and thus 
Ptdlns(4,5)P,. 
The values for the Ins( 1,4,5)P, content of the various human leucocytes ranged 
from 3 pM to 5 PM. Values of the same order of magnitude were found for mouse 
peritoneal and alveolar macrophages as well as for activated peritoneal macrophages 
(results not shown). The present values are comparable to those obtained for 
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Dictyostelium discoideum micro-organisms (13) and 3T3 fibroblasts (22) with the 
competition binding assay, for AR42J pancreatoma cells using the isotopic equilibrium 
method (3), and for MDCK cells using mass spectrometry of separated, hydrolysed, and 
derivatised Ins( 1,4,5)P, (8). However, the present Ins( 1,4,5)P, values are considerably 
higher than those obtained for human platelets with an enzymatic method (10) and for 
rabbit peritoneal neutrophils with a different competition binding assay (9). The reasons 
for divergent Ins(1,4,5)P, values found with the present competition radiobinding assay 
and that employed by Bradford and Rubin (9) are not clear. One possible explanation for 
this discrepancy, i.e. the intracellular Ins( 1,4,5)P, content of neutrophils from two species 
differs, can be excluded, since we found that the Ins(1,4,5)P, content of rabbit neutrophils 
(68+14 pmol Ins(1,4,5)PJ108 neutrophils) is about the same as the value for human 
neutrophils. 
A great advantage of the present method is the large reduction in costs and 
number of cells required in comparison to the commercial kit. Since we prepared the 
Ins( 1,4,5)P,-binding material ourselves, which takes about one day to isolate 
adrenalcortical material sufficient for 8,000 determinations, and diminished the volume of 
the various components of the binding assay, the price was reduced from about 20 US 
dollars to 1 US dollar per sample. The number of cells required to prepare a cell lysate 
was reduced from 1x10’ to 2x106 cells. These advantages led us to quantify the changes 
in the Ins(1,4,5)P, content of human leucocytes during f-MLP stimulation. 
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